Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| metastatic prostate carcinoma |
|
Metastatic prostate carcinoma to bone time from diagnosis of metastatic prostate carcinoma to surgery for metastatic prostate carcinoma. (D) Kaplanâ“Meier curve for cancer-specific survival and The metastatic potential of prostate carcinomas composed entirely P.N. Brawn and C.F. Johnson III: Metastatic prostate carcinoma nodes may be one of the initial sites of metastatic. prostate carcinoma since some Treatment of Metastatic Prostate Carcinoma with Radiolabeled Treatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49. Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, Walter E. Plott, Treatment of renal cell carcinoma and prostate carcinoma Treatment of renal cell carcinoma and prostate carcinoma metastatic to the spine and skull. Meeting: 2003 ASCO Annual Meeting Abstract No: 1776 First CiNii - Metastatic Prostate Carcinoma to the Mandible : Report of We report a case of metastatic prostate carcinoma to the mandible. A 76-year-old male was referred to our hospital due to a complaint of swelling in the Arch Dermatol -- Abstract: Metastatic prostate carcinoma Metastatic prostate carcinoma manifesting as penile nodules. F. C. Powell, P. Y. Venencie and R. K. Winkelmann. In three patients with prostate carcinoma, Hyaluronan synthase elevation in metastatic prostate carcinoma Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone IngentaConnect Metastatic prostate carcinoma presenting as Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy - is it unusual? Authors: Ahamed, S.H.1; Agarwal, A.K.1; Raju, PPJ2 AJNS - African Journal of Neurological Sciences The enhancement pattern on CT scanning seen in metastatic prostate carcinoma to the dura in this case is similar to that seen in intracranial meningiomas. Prostate Carcinoma Metastatic to the Cervical Lymph Nodes: Report agnosis of metastatic prostate carcinoma was. traditionally difficult, but has sensitive and specific for metastatic prostate. carcinoma. 18,24,27 Metastatic Prostate Carcinoma Presenting as Supraclavicular Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy is not as uncommon as one would expect. Butler et al.1 described 19 patients NEJM -- Case 21-2004 - A 63-Year-Old Man with Metastatic Prostate Case 21-2004 â” A 63-Year-Old Man with Metastatic Prostate Carcinoma was evaluated in the clinic because of metastatic prostate cancer that was no longer MIR Teaching file case bs054 92-year old man with known metastatic prostate carcinoma. The patient had complaints of diffuse bony pain, most severe in the back. Cutaneous metastases from carcinoma of the prostate: A case report Prostate carcinoma is usually adenocarcinoma and has a high metastatic potential. It usually spreads to bones, liver, and lungs 11. Prostate cancer - Wikipedia, the free encyclopedia "A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma". J Natl Cancer Inst 94 (19): Metastatic prostate carcinoma to bone: clinical and pathologic BACKGROUND: The objective of this study was to examine the clinical and pathologic features of metastatic prostate carcinoma to bone in a large cohort of Bonetumor.org - The Web's Most Comprehensive Bone Tumor Resource In advanced stages of prostate carcinoma, it can metastasize to various regions . The overall failure rate of metastatic prostate cancer alone was 10%. eMedicine - Prostate Cancer: Metastatic and Advanced Disease I. The effect of castration, estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7. eMedicine - Prostate Carcinoma : Article by Richard Clements Synonyms and related keywords: prostate carcinoma, prostatic cancer, Media file 15: Metastatic prostate cancer (arrows) involves the soft tissues at |
| metastatic prostate carcinoma |
|
herb infection pill prostate how to stimulate your prostate laparoscopic prostatectomy robotic procedure for prostate cancer |